Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + magnesium sulfate vs amiodarone + magnesium sulfate for prevention of ventricular fibrillation after aortic clamp removal in CABG
IRCT2015081723660N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine, amiodarone and magnesium sulfate in ventricular fibrillation (VF) and coronary arteriosclerosis (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Incidence of ventricular fibrillation after aortic cross-clamp removal. Started Mar 2015; status: completed.
02
Drugs
lidocaineamiodaronemagnesium sulfate
03
Conditions
ventricular fibrillation (VF)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT2015081723660N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015081723660N1.